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Daniel Lopata

Bowman v. Monsanto: Agriculture’s Implications for…technology?

I.

Introduction
The decision in the agricultural battle between Monsanto and Bowman has implications

beyond agriculture. Experts in the technology sector are observing the decision the Supreme
Court is set to issue soon. That very decision will decide the path that software and technology
will take to protect any infringement of their intellectual property.

The agricultural

biotechnology giant Monsanto is once again embroiled in a lawsuit, this time against seventyfive year old Indiana farmer Hugh Bowman. Monsanto is accusing Bowman of infringing on its
genetically modified seed patents. Bowman allegedly used second-generation seeds to plant his
crops for a period of eight years. The company says that by not buying seeds for each generation,
Bowman violated its patents and the technology Monsanto has with Bowman.
Bowman is arguing that the patent exhaustion doctrine should apply. Bowman purchased
the patented seeds from a third party; specifically, a grain elevator. Bowman’s legal team claims
that Monsanto does not have patent rights in the resale of its product from a third party. The
doctrine is derived from old common law cases, to be discussed below; there judges found that a
resale of an item exhausts or extinguishes a patent owner’s rights in the intellectual property.
The implications for each side are huge. A victory for Monsanto would secure its patents
against other infringers who similarly use Monsanto’s self replicating generation seeds and
strengthen its position as the primary supplier of agricultural products. A victory would
strengthen Monsanto’s position since now every supplier of Monsanto’s patented seeds and
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every purchaser would be required to remit royalty payments to Monsanto. A victory for
Bowman would ensure that companies find alternative methods to protect their intellectual
property; companies may resort to the development of terminator technology as a result of a
Bowman victory. Terminator technology ensures that seeds would not be able to produce
second-generation offspring. Currently, Monsanto rejected the use of terminator seeds. The
ramifications of Bowman’s victory would also spill over into software, where technology firms
are concerned that a Supreme Court decision in favor of Bowman would facilitate software
piracy.
Both Bowman and Monsanto argued their respective points before the Supreme Court in
February. During oral argument, the Supreme quickly jumped on Bowman’s attorney mere
seconds into his argument. The Supreme Court concerned itself and Bowman’s attorney with the
question as to what motivation would intellectual property producers have to develop new
technologies and even bother patenting them if their rights evaporate so quickly. Shortly
thereafter, members of the Supreme Court openly stated, in a matter of fact way, that Bowman
openly infringed Monsanto’s patent. While questioning is often inconclusive and it is impossible
to predict the Supreme Court’s determination, it appears from oral argument that Bowman’s ship
is quickly sinking. In turn, technology patent owners are rejoicing.

II.

Science Behind Genetic Modification
While information on the history of early genetic modification is sparse, it is historically

known that humans have played a role in plant and animal breeding since they made a transition
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from the hunter-gatherer societies to the Neolithic domestication period around 10,000 B.C. 1
According to a study of early man by Australia National University’s academic historian
William Gammage, people selectively bred animals such as dogs on their farms. 2 Humans
selectively bred other animals for their diets and chose plants that produced a favorable yield in
the conditions in which they lived.3 This allowed people to have more prosperous harvests and
increased their chances of having food, which hunting did not offer.4
If we fast-forward to modern times, we see that the origins of genetically modified
organisms began with the discovery of DNA and the understanding of recombinant DNA. The
pairing of bases in DNA, which was brought to light by Watson and Crick in 19535, provided a
clear mechanism of the methodology that organisms use to copy their genetic information. 6
Without this vital piece of information, scientists such as Paul Berg, who in 1972 created the first
recombinant DNA molecule by combining genes from two different virus organisms, would not
have otherwise been possible.7
Once scientists were able to discover the model and basis for DNA, they were able to
alter the instructions of any cell and organism that they needed to.8 Thus, they engineered plants

1

WILLIAM GAMMAGE, LONDON PAPERS IN AUSTRALIAN STUDIES 1-27 (Menzies Centre for
Australian Studies eds., 2005).
2
Id.
3
Id.
4
Id.
5
The Discovery of the Molecular Structure of DNA - The Double Helix, available at
http://www.nobelprize.org/educational/medicine/dna_double_helix/readmore.html?referer=www
.clickfind.com.au (last visited Mar. 21, 2013).
6
Id.
7
Id.
8
National Human Genome Research Institute (NHGRI), Deoxyribonucleic Acid, available at
http://www.genome.gov/25520880 (last visited Mar. 21, 2013).
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to have the traits that were desirable for Monsanto.9 A cell that is genetically modified will pass
on those traits to its offspring just as any other cell would because the instructions that were
programmed into the DNA are part of the organism.10
The DNA molecule or deoxyribonucleic acid molecule contains instructions and both are
passed down from the previous generation to the next. During the process of replication as well
as protein synthesis, the DNA molecule unwinds from its tightly wound form from within the
nucleus, exposing the sequence which instructs the cell to perform the required process. The
DNA molecule is composed of varying sequences of nucleotides, which contain one of four
nitrogenous bases called adenine, thymine, guanine, and cytosine.11 In addition to a base, the
nucleotide contains a phosphate group and a deoxyribose sugar group on the outside of the
base. 12 The nucleotide is considered to be a building block of the genome because it is a
component of the instructions for the organism.13 Each sequence of the nucleotides containing
the different bases has different instructions for every individual organism. 14 Two chains of
nucleotides join together to form a double helix with the attaching bases being complimentary to
each other.15 The adenine joins the thymine and the guanine joins the cytosine. 16 The double
helix of the DNA is like a winding ladder, and this trait contributes to the DNA’s ability to pass
instructions to the next generation and or create a protein.17 A single complementary base pair

9

History of Monsanto Corp., available at
http://www.monsanto.com/whoweare/Pages/monsanto-history.aspx (last visited Mar. 21, 2013).
10
NHGRI, supra note 8.
11
Id.
12
Id.
13
Id.
14
Id.
15
Id.
16
Id.
17
Id.
4

can be likened to that of a single step of the ladder.18 The complementary pairs are joined by
either two or three hydrogen bonds.19 The cytosine and guanine are bonded together via three
hydrogen bonds and have a stronger link together than the two hydrogen bonds that keep adenine
and thymine bonded.20
The two chains of the helix run in opposite directions and are anti-parallel.21 One side
runs in the five prime to three prime direction, while the complimentary strand runs the same, but
in the opposite direction.22 The three and five indicate the directions in which the carbons on the
sugars face.23 A phosphodiester linkage connects the sugars of the DNA to each other, which is a
phosphate group that connects the third carbon on one nucleotide to the fifth on the next sugar. 24
Yet, only one strand can be used as a template strand during the process of proteins synthesis.25
It is from that strand and not its complimentary one that DNA is transcribed into mRNA, which
is used to construct proteins.26 This process requires great precision because there are twenty
different amino acids that can be used to make up the protein.27
These revolutionary ideas were the predecessor for and allowed the US to have the ability
to mass-produce and sell the first genetically modified crops called the Flavr-Savr tomatoes in

18

Id.
Id.
20
Id.
21
Id.
22
University of Illinois at Chicago, DNA Structure, available at
http://www.uic.edu/classes/phys/phys461/phys450/ANJUM04/ (last visited Mar. 21, 2013).
23
Id.
24
Id.
25
Id.
26
NHGRI, supra note 8.
27
Id.
19
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1994.28 These tomatoes synthesized less products that otherwise would cause them to spoil in
shorter periods of time.29 Although China preceded the US in releasing a transgenic crop to the
masses since the 1980s, today, America is the market leader in genetically engineered
agricultural products.

30

Countries worldwide purchase and grow transgenic seeds from

companies like Monsanto. These genetically modified crops include, but are not limited to:
insecticide sweet corn, which produces a toxin that eliminates the need for insecticide spraying,
golden rice, which contains beta-carotene that is essential for the human body to make vitamin
A, as well as potatoes, among many others that people include in their diets each day.31
The process of genetically engineering seeds is a complex one, but it begins with the
simple step of isolating a desired trait to incorporate into a plant.32 After one obtains the desired
trait, the goal is to incorporate the novel gene into the genome of the plant seed.33 This can be
done via several different methods. One way of doing this is by implementing the gene gun,
which shoots fragments of desired DNA sequences using a .22-caliber charge with the DNA
covering a particle of metal.34 Companies may implement another method that uses heat to make
the seeds vulnerable to Agrobacterium tumefaciens.35 Scientists use this organism to incorporate

28

Food and Water Watch, Genetically Engineered Food, available at
http://documents.foodandwaterwatch.org/doc/GeneticallyEngineeredFood.pdf, (last visited Mar.
21, 2013).
29
Id.
30
Genetic Modification Education, A Brief History of Genetic Modification, available at
http://www.gmeducation.org/faqs/p149248a%20brief%20history%20of%20genetic%20modifi
cation.html (last visited Mar. 21, 2013).
31
Bionet, 4 Examples of Genetically Modified Crops, available at
http://www.bionetonline.org/english/content/ff_cont3.htm (last visited Mar. 21, 2013).
32
Rebecca Boyle, How to Genetically Modify a Seed, Step by Step, POPSCI (Jan. 24, 2011, 2:56
PM), available at http://www.popsci.com/science/article/2011-01/life-cycle-geneticallymodified-seed (last visited Mar. 21, 2013).
33
Id.
34
Id.
35
Id.
6

novel genes into the plant’s genome.36 The benefit of implementing this method is that it is able
to evade the plant’s natural defenses, and the seed will recognize the novel gene as part of its
genetic makeup.37 Future seeds that will come from this altered seed will possess the new trait
that the scientists have incorporated into the plant.38
In the case of the disputed Roundup Ready soybean seeds produced by Monsanto,
scientists discovered a gene in a soil agrobacterium CP4 strain called the CP4 EPSPS gene
located near their factory in St. Louis, Missouri.39 The bacterium has 5-enolpyruvoyl-shikimate3-phosphate synthetase (EPSPS), which is an enzyme that provides resistance against glyphosate
found in Roundup. 40 The scientists then cloned the gene found in these organisms using
Escherichia coli in order to increase their numbers.41 Finally, they used A. tumefaciens to insert
the desired isolated gene into the soybean seed genome along with a promoter to aid in
recognition and copying of the genetic information by the seed’s natural mechanisms.42 This
completes the work done by the company, but it is up to the seeds to continue the work from
there.
Once the scientists obtain the desired sequence, the seed takes over upon planting and
performs two important steps in order to regulate the plant’s behavior in the growth and
maintenance of its life. 43 They are the transcription and translation of the genetic sequence

36

Id.
Id.
38
Id..
39
International Service for the Acquisition of Agri-Biotech Applications (ISAAA), Roundup
Ready Soybean, available at http://www.webcitation.org/60hS1x2BS (last visited Mar. 21, 2013).
40
Jeremy McDermott, New Super Strain of Coca Plant Stuns Anti-Drug Officials, The Scotsman
(Aug. 8, 2004, 12:56 AM), available at http://www.scotsman.com/news/international/new-superstrain-of-coca-plant-stuns-anti-drug-officials-1-550814 (last visited Mar. 21, 2013).
41
Boyle, supra note 32.
42
ISAAA, supra note 39.
43
Id.
37
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necessary for producing needed proteins. The plant’s modified DNA is the instruction guide,
which directs the plant to make necessary proteins for the plant to function properly.44 Yet, the
DNA needs to be transcribed or copied into a temporary form of RNA called mRNA or
messenger RNA.45 This is done using an enzyme called an RNA polymerase, which forms the
sequence of mRNA. 46 In order for this to occur, the transgenic seeds use Monsanto’s 35S
promoter from the Cauliflower mosaic virus (CaMV) in order to activate foreign genes, which
were inserted from the A. tumefaciens into the soybean seed. 47 The benefit of implementing
CaMV promoter is that it can transcribe the whole genome and leads to high levels of gene
expression in soybean plants.48 This results in the incorporation of genetic information that codes
for EPSPS. Transcription is followed by a step called translation. In this process, the ribosome
within the plant cell reads the mRNA, which dictates the exact amino acids that are to be
assembled to form a protein.49 If there is no protection against the glyphosate toxin, also known
as N-phosphonomethylglycine by its chemical name, the plant would be unable to perform these
necessary steps to produce proteins.50 The EPSPS is essential in producing resistance in crops
against the glyphosate in the Roundup herbicide intended to kill weeds.51 Without this protection,
it would normally kill soybean crops after contact with the toxin.52 This allows the farmers to

44

Id.
Id.
46
Id.
47
Id.
48
Wei Pelechano, Al Jaervelin, and Lars Steinmetz, Functional Consequences of Bidirectional
Promoters, US National Library of Medicine (May 24, 2011), available at
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123404 (last visited Mar. 21, 2013).
49
ISAAA, supra note 39.
50
Id.
51
Herbicide Tolerance and GM Crops (Jun. 2011), available at
http://www.greenpeace.org/international/Global/international/publications/agriculture/2011/363
%20-%20GlyphoReportDEF-LR.pdf (last visited Mar. 21, 2013).
52
Id.
45
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prevent weeds from infesting their fields because they are able to continue implementing their
desired herbicide.53 They can also protect their crops at the same time without losing money and
crops to the herbicides.54

III.

Applicable Patent Law
A. Statutory Law and Common Law
In the United States, patent law is codified under Title 35 U.S.C. §101 et seq. Patent law

is authorized by the United States Constitution from Article One, section 8(8), which reads [t]he
Congress shall have power...To promote the progress of science and useful arts, by securing for
limited times to authors and inventors the exclusive right to their respective writings and
discoveries.55
Title 35 is split into four parts with numerous additional provisions allocated within each
part. The first part establishes the United States Patent and Trademark Office (USPTO) and
authorizes the USPTO to grant and issue patents and register trademarks. 56 The second part
governs what is patentable and what requirements a particular invention must meet to be eligible
to receive a patent.57 The third part deals with the protection of patents and holder’s rights.58 The
fourth part concerns itself with the Patent Cooperation Treaty; an international document to
protect patents rights oversees.59 However, Bowman v. Monsanto involves a principle not found
codified in in Title 35. Patent owners generally have the entire statutory patent term, currently set

53

ISAAA, supra note 39
Id.
55
U.S. Const. article 1, § 8, cl. 8.
56
35 U.S.C. §§ 1–42 (2012)
57
35 U.S.C. §§ 100-212 (2012).
58
35 U.S.C. §§ 251–329 (2012).
59
35 U.S.C. §§ 351–376 (2012).
54
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at 20 years from filing under 35 U.S.C. §154(a)(2), over which to recover their research and
development costs.
A modern U.S. patent consists of two basic parts: a specification and one or more
claims.60 The specification portion includes a written description and diagram with information
depicting the proposed patent.61 The specification and diagram describe the proposed patent and
serves to inform those proficient in the particular area of the proposed patent on how to utilize
the invention.62 The final sentences of the proposed patent end with one or more claims about the
patent63 , which consist of a single sentence describing what the patent owner defines as the
patented invention. 64 The claim must "particularly point out and distinctly claim the subject
matter which the applicant regards as his invention."65 Patent law requires both the specification
and at least one patent claim. 66 Once granted by the USPTO, the patent, containing the
specification and one or more patent claims, becomes publicly available.67
There are two purposes served by the submission of a patent claim to the USPTO . First, the
claim acts as a notice function.68 The claim puts the entire world on notice about what is seeking to be

patented and by whom.69 The claim seeks to inform the public of the exact scope ofexclusivity granted
by the patent.38 Second, the patent claim performs a substantive function that goes beyond what is

available to the public.70 The patent claim uses patent law to define the scope of protection that is

60

35 U.S.C. § 112 (2012).
Id.
62
Id.
63
Id.
64
Id.
65
Id.
66
Id.
67
35 U.S.C. § 122(b)(1) (2012).
68
Texas Digital Sys. Inc. v. Telegenix, Inc., 308 F.3d 1193, 1202 (Fed. Cir. 2002).
69
Id.
70
Aro Mfg. Co. Inc. v. Convertible Top Replacement Co., 365 U.S. 336, 339 (1961).
61
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being sought.71 This functions to outline the subject matter that only the patentee may practice.72
Therefore, submission of a patent claim performs both definitional and public-notice functions. 73

That being said, a significant part of Bowman v. Monsanto involves the common law
theory of exhaustion rights, otherwise known as the first sale doctrine. The Supreme Court first
recognized the patent exhaustion doctrine in 1873 in the seminal case of Adams v. Burke.74 This
common law patent doctrine represents the proposition that once an unrestricted authorized sale
of the patented material occurs, the patent holder’s exclusive right to control the subsequent use
and sale of that article is gone, or exhausted.75 An unrestricted authorized sale is defined as a sale
where the patent holder cannot suppress the sale of the item.76 In other words, since the patent
holder no longer has rights to the patented device, the purchaser of the patented material is free
to use or resell the patented material without consideration of the patent holder’s rights in that
article.77 Under the current state of the law the purchaser is expressly forbidden from re-growing
or re-creating the patented article, unless specifically authorized by the patent holder.78 With the
first unrestricted sale of a patented article, the patent holder’s voluntary introduction of that into
commerce prevents the patent holder from exercising his or her right to exclude others from
using or reselling the patented material.79

71

Id.
McClain v. Ortmayer, 141 U.S. 419, 424 (1891).
73
Texas, supra note 68.
74
Adams v. Burke, 84 U.S. 453 (1873)
75
Monsanto Co. v. Scruggs, 459 F.3d 1328, 1336 (Fed. Cir. 2006).
76
Interdigital Technology Corp. v. OKI America Inc., 803 F.2d 684, 687 (Fed. Cir. 1986).
77
Scruggs, supra note 75.
78
Id.
79
United States v. Univis Lens Co., 316 U.S. 241, 251 (1942).
72
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There are two important limitations of the patent exhaustion doctrine. The first limitation
is the sale of an incomplete article.80 An incomplete article is one that is a component of a greater
part. For example, in Univis Lens, the court held that a single lens blank that was used in
producing more lenses was incomplete. 81 In these situations, exhaustion is applicable to the
authorized sale of an incomplete article if: (1) its “only reasonable and intended use was to
implement the patent, and (2) it “embodies essential features” of the patented invention.82 For
example, in Quanta Computer, the court said that patented LG components in Intel processors
were useless without connecting them to other components, which is what Quanta did. 83 In
clearer language, the supplier of components of cannot claim patent rights in the finished
device.84
The next significant limitation is known as the sales limitation. The body of law setting
forth the scope of this limitation restricts the sale or use of the patented material beyond the first
sale when the patented material is actually in the possession of the customer or purchaser of the
patented material. 85 In addition to being found in Monsanto’s technology agreement, this
limitation is commonly seen in software agreements. This limitation arose in the 1992 case of
Mallinckrodt, Inc. v. Medipart. 86 Unfortunately, the extent of this limitation is unclear under
current law. Bowman v. Monsanto should be the deciding case whether Mallinckrodt is still good
law.
B. Case law

80

Id.
Id.
82
Quanta Computer, Inc. v. LG Electronics, Inc., 553 U.S. 617, 631-32 (2008).
83
Id.
84
Id.
85
General Talking Pictures Corp. v. Western Electric Co., 304 U.S. 175 (1938).
86
Mallinckrodt, Inc. v. Medipart, Inc., 976 F.2d 700 (Fed. Cir. 1992).
81
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A number of cases were brought up above relevant to the law at issue in Monsanto v.
Bowman. This section will introduce the facts and holdings of several key cases.
The first to be discussed is Monsanto Co. v. Scruggs, 459 F.3d 1328 (Fed. Cir. 2006).
Scruggs has facts closely relating to the facts in the instant case of Bowman v. Monsanto. Like in
Bowman, Monsanto licensed the patents for herbicide and insecticide resistant soybeans to seed
companies.87 Under the license agreement, those seed companies were permitted to incorporate
the genetic material into their own germplasm to produce herbicide resistant and insect resistant
seeds.88 The licensing agreement also had a provision that the seed companies could sell the
resulting genetically modified seeds only to farmers who entered into license agreements with
Monsanto. 89 Additionally, the license agreements with farmers prohibited the farmers from
replanting the genetically modified seed from the crops grown.90
The defendant, Scruggs, a farm limited liability company run by its namesake farmer and
his family, bought seeds containing Monsanto’s patented technology but never signed the license
agreement.91 Scruggs planted the first generation seeds, and then replanted the second-generation
seeds after the first harvest. 92 Scruggs did not sell any of the seeds. 93 Monsanto then sued
Scruggs for infringing on its herbicide and insecticide patent.94 Scruggs denied any infringement
and argued that the patents at issue were invalid. 95 Scruggs also retaliated with antitrust and

87

Scruggs, supra note 75.
Id.
89
Id.
90
Id.
91
Id.
92
Id.
93
Id.
94
Id.
95
Id.
88
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patent misuse claims.96 Scruggs also denied infringement and claimed that the patents at issue
were invalid. The trial court granted summary judgment on all issues for Monsanto, and the
Federal Circuit affirmed on most of the issues.97
Part of the argument in the Scruggs case was the exhaustion doctrine.98 Scruggs argued
that argued that he purchased the Monsanto seeds in an unrestricted sale, and that he was
therefore entitled to use those seeds in an unencumbered fashion under the doctrine of patent
exhaustion.99 Scruggs claimed that under the doctrine of patent exhaustion, he could use or sell
the purchased seeds in whatever fashion he wanted. 100 Unfortunately for Scruggs, the court
quickly rejected his argument. 101 The court stated that the doctrine was inapplicable in that
case.102 The court went on to say “[t]here was no unrestricted sale because the use of the seeds by
seed growers was conditioned on obtaining a license from Monsanto. Furthermore, the ‘first sale’
doctrine of exhaustion of the patent right is not implicated, as the new seeds grown from the
original batch had never been sold.”103 Thus, it appears that unless there is an actual sale of the
second-generation seeds, the patent exhaustion doctrine is not implicated. Merely being able to
replicate a patented technology does not give the copier a right to use that replicated
technology. 104 The Scruggs court was aware that opening the floodgates by applying the

96

Id.
Id.
98
Id.
99
Id. at 1336.
100
Id.
101
Id.
102
Id.
103
Id.
104
Id.
97
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exhaustion doctrine to subsequent generations of self-replicating technology would kill the rights
of the patent holder.105
The next case to tackle is Quanta Computer, Inc. v. LG Electronics, Inc., 553 U.S. 617
(2008). In that case, LG, an electronics manufacturer, owned several patents on methods and
systems for processing information. 106 LG then entered into several agreements with Intel, a
major computer component manufacturer and developer. 107 Embodied within the agreement,
Intel would be permitted to use LG’s patents in creating and selling its microprocessors.108 Also
writing into the agreement, LG included a provision that its patent would not be exhausted in
subsequent sales of Intel processors using LG’s patented methodology.109
Quanta, the world’s largest manufacturer of laptops and hardware, purchased Intel
processors and included them in its computers. 110 In incorporating Intel processors in its
machines, Quanta used LG’s patented methodology, since that was the only way Intel designed
its processors to be included in computers.111 Unfortunately, the record is sparse with facts and
information, apparently in an attempt to protect trade secrets. Regardless, LG sued Quanta for
violating its patents.112
In trial court, Quanta prevailed on the patent exhaustion claims.113 In federal court, the
court reversed the patent exhaustion claims.114 The Supreme Court reversed the federal court,

105

Id.
Quanta Computer, Inc. v. LG Electronics, Inc., 553 U.S. 617 (2008).
107
Id.
108
Id.
109
Id.
110
Id.
111
Id.
112
Id.
113
Id.
114
Id.
106
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and allowed Quanta’s patent exhaustion claim. 115 The court found that all the patents were
already incorporated into the Intel microprocessors, which embody the essential features of the
patents because they carry out all the inventive processes when combined with standard
components.116 In effect, the court stated that LG’s patent was exhausted when Intel sold its
processor to Quanta.117
The next significant case is United States v. Univis Lens Co., 316 U.S. 241 (1942). In
Univis, the Univis Lens Company owned method and product patents on optical lenses.118 Univis
developed lens blanks, which would then be sold and ground and polished to become the final
patented product.119 The final product was then sold at prices that were fixed by Univis.120 The
entire point of selling the blanks was to manufacture the patented lenses.121 The court held that
the exhaustion doctrine exhausted the patent protection of the blanks.122 The court wrote that the
patent is exhausted “[w]hether the licensee sells the patented article in its completed form or sells
it before completion for the purpose of enabling the buyer to finish and sell it.”123 The Univis
case has been upheld in later decisions such as Quanta.124

IV.

Bowman vs. Monsanto

a.

Facts

115

Id.
Id.
117
Id.
118
Univis, supra note 79.
119
Id.
120
Id.
121
Id.
122
Id.
123
Id. at 244.
124
Quanta Computer, Inc. v. LG Electronics, Inc., 553 U.S. 617 (2008).
116
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Monsanto Company (“Monsanto”) is a publicly traded American agricultural
biotechnology corporation headquartered in Missouri. Monsanto is one of the leading producers
of genetically engineered seeds and herbicides. In 1983, Monsanto was one of the first
companies to create a genetically modified plant cell.125 Four years later, in 1987, the company
was able to actually conduct field trials using its genetically modified seeds.126 The first field
trials used soybeans with Roundup Ready resistance.127
Monsanto’s business model focuses heavily on research and development. 128 Through
heavy spending on researching and developing new products, the company develops herbicides
and patents genetically modified seeds.129 The company then recovers its costs from the sale of
its products to the agricultural sector and strict enforcement of its patents.130 Due to Monsanto’s
austere enforcement measures, farmers and advocates have heavily criticized the company.131
Monsanto is known as the firm that designs herbicide resistant soybeans, which are called
“Roundup Ready”, due to the soybeans’ resilience to Roundup, an herbicide created by the
company.132 The two patents at issue, Patent No. 5,352,605 ("605") and Patent No. RE39, 247

125

Colorado State University, available at http://cls.casa.colostate.edu/transgeniccrops/how.htm
(last visited Mar. 21, 2013).
126
History of Monsanto Corp., available at
http://www.monsanto.com/whoweare/Pages/monsanto-history.aspx (last visited Mar. 21, 2013).
127
Id.
128
Keith Schneider, Betting the Farm on Biotech (Jun. 10, 1990), available at
http://www.nytimes.com/1990/06/10/magazine/betting-the-farm-onbiotech.html?pagewanted=all&src=pm (last visited Mar. 21, 2013).
129
Id.
130
Id.
131
Vandana Shiva, The Seed Emergency: The Threat to Food and Democracy (Feb. 6, 2012),
available at http://www.aljazeera.com/indepth/opinion/2012/02/201224152439941847.html (last
visited Mar. 21, 2013).
132
History of Monsanto Corp., available at
http://www.monsanto.com/whoweare/Pages/monsanto-history.aspx (last visited Mar. 21, 2013).
17

("247E"), involve different parts of the herbicide resistance technology.133 The 605 patent applies
to a process by which Monsanto combined two different sequences of DNA to create a new gene
called a chimeric gene.134 These chimeric genes then give the plant new characteristics, such as
herbicide resistance.135 The 247E patent uses the process in the 605 patent to create chimeric
genes in soybean plants that makes them compatible with herbicides.136
Monsanto sells these herbicide resistant soybeans to suppliers and licenses the herbicide
resistance technology to seed producers.137 In their Technology Agreement, Monsanto limits the
use of their seeds and technology to a single season and prohibits supplying it to a third party or
replanting second generation seeds.138 Second generation seeds are the product of soybean plants
grown from original seeds.139 Although the Agreement generally prohibits growers from selling
second-generation seeds for replanting, Monsanto does allow growers to sell them to local grain
silos to be used as animal feed or to be sold as a commodity. 140 Commodity seeds are a
collection of many different types of seeds from local growers that are purchased for a variety of
uses, such as livestock feed.141
Under the agreement, the licensed grower or farmers agree to a number of provisions.142
The first relevant provision is to use the seed with Monsanto’s patents for planting a commercial

133

U.S. Patent No. 5,352,605 (issued Oct. 4, 1994); U.S. Patent No. RE39, 247 (issued Aug.22,
2006).
134
Id.
135
Id.
136
Id.
137
Monsanto Co. v. Bowman, 657 F.3d 1341 (Fed. Cir. 2011).
138
Id.
139
Id.
140
Id.
141
Id.
142
Monsanto Technology Agreement, available at
http://thefarmerslife.files.wordpress.com/2012/02/scan_doc0004.pdf (last visited Mar. 21, 2013).
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crop for only a single season.143 Second, the licensee agrees to not supply the seed to anyone else
for planting. 144 Third, the licensee agrees that it will not save any crops produced from
Monsanto’s seed for replanting or share the saved seed with anyone else for replanting.145 Fourth,
no one shall use this seed for crop breeding, research, or seed production.146 As mentioned before,
Monsanto does permit licensees to sell the second generation of the seeds for commodity
purposes.147
At issue in Monsanto v. Bowman, Indiana farmer Vernon Hugh Bowman purchased
seeds from Pioneer, a registered seed producer of Monsanto. 148 As required by Monsanto,
Pioneer had Bowman sign an agreement identical to Monsanto’s Technology Agreement, which
limited the use of the seeds to a single season and mandated that Bowman comply with
Monsanto’s terms and conditions. 149 Monsanto also sent Bowman a letter directly, which
informed Bowman that he could not replant any form of Monsanto’s herbicide resistant seeds.150
Bowman regularly purchased seeds from Pioneer from approximately 1999 until 2007. 151 In
following the terms and conditions of the agreement with Monsanto and Pioneer, Bowman did
not save his seeds from the first planting or in any subsequent year.152
In 1999, Bowman also purchased seeds from a local commodity seed provider, who sold
seeds for solely for the purpose of feed, not planting, and planted a second crop against the terms
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and conditions of Monsanto.153 Since Bowman considered the second-crop to be a higher risk for
planting, he purchased the commodity seed from the grain elevator to avoid paying the
significantly higher price for Roundup Ready seeds.154 That same year, Bowman applied the
Roundup herbicide to the fields in which he had planted the second-hand grain elevator seeds to
control weeds and to determine whether the plants would exhibit herbicide resistance. 155 He
confirmed that many of the plants were, indeed, resistant.156 Thereafter, with each subsequent
year, from 2000 through 2007, Bowman treated his second crop with Roundup herbicide.157 With
this second crop, Bowman saved the seed harvested for replanting additional second crops in
later years.158 He also supplemented his second crop planting supply with additional purchases of
commodity seed from the grain elevator.159 Bowman did not attempt to hide his activities, and he
candidly explained his practices with respect to his second-crop soybeans in various
correspondences with Monsanto’s representatives between 2006 and 2007.160
In winter of 2006, Monsanto became aware of Bowman’s planting practices and
investigated his use of herbicide resistant seeds. 161 Monsanto investigated eight fields that
Bowman owns, totaling approximately 299 acres and confirmed that the second crop seeds that
Bowman was planting contained their Roundup Ready gene. 162 Upon confirmation that
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Bowman’s second crops displayed herbicide resistance, Monsanto sued him for patent
infringement of its 605 and 247E patents.163
b.

Procedural History
In the Federal District Court, the Southern District Court of Indiana dismissed Bowman’s
claims on summary judgment. 164 Bowman brought a defense of patent exhaustion and that
Monsanto failed to provide actual notice of infringement to him.165 The court found Bowman’s
argument compelling, yet decided that the case relied on by Bowman, Scruggs 166 , was
distinguishable from Bowman’s situation.167 In Bowman’s case, there was a license agreement
that Monsanto had him sign whereas there was no license agreement in Scruggs or the other
cases Bowman relied on.168 The court additionally made a policy judgment that agreeing with
Bowman would eviscerate patent holders’ rights in their technology and hard work. 169
Furthermore, the court held that the patent exhaustion is inapplicable.170 Bowman argued that the
seeds from one generation are identical to the next generation, thus adopting a robust exhaustion
doctrine that encompasses the progeny of seeds and other self-replicating technology. 171
Monsanto counters this by arguing that the seeds are governed by the technology agreement and
are not intended for planting.172
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The Court of Appeals for the Federal Circuit found that Monsanto’s patent rights in the
seeds were not exhausted once sold to a commodity dealer. 173 The Federal Circuit further
reasoned that although Monsanto’s patented technology can replicate itself, a buyer could not use
the product of replication because it would eliminate Monsanto’s patent rights. 174 The court
concluded that Bowman retained the right to sell second-generation seeds as feed or for any
other number of uses, but he was prohibited from replanting them in any form.175
On December 20th, 2011, Petitioner Hugh Bowman filed a writ of certiorari to the United
States Supreme Court. After both sides filed supporting and opposing briefs, with twenty-five
amicus briefs filed176, the Supreme Court granted the writ of certiorari on October 12, 2012.177
On February 19, 2013, oral arguments were heard before the Supreme Court. 178 As of this
writing, a decision is still pending with an uncertain release date.179
During oral argument, the court hinged on why anyone would want to develop patents if
they would lose rights to them after the first generation.180 Good answers to that question would
be to use contract law to supplement patent law and to argue that not all seeds are fungible. The
second argument is exactly what Bowman’s counsel replied to the court. 181 Next, the court
inquired as to whether the exhaustion doctrine even applies. The court stated that the law never
allows one to make a copy of the seed and use it without a license, since the progeny would be a
173
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new item.182 In reference to Buck v. Bell, Justice Breyer humorously replied, “three generations
of seed are enough.”183 Bowman’s lawyer answered the inquiry into the exhaustion doctrine by
replying that this is a new case involving the exhaustion doctrine with self-replicating
technology.184

V.

Implications for Software
The question in Bowman v. Monsanto involves second-generation seeds that were not the

subject of an authorized sale. As the court of appeals correctly concluded, once a grower, such as
Bowman, plants the commodity seeds that contain Monsanto’s Roundup Ready technology and
the next generation of seed develops, the grower has created a newly infringing article.
Any tampering with patent rights in Bowman v. Monsanto would effectively shorten the
patent term for patents covering artificial, software, biotechnology, and progenitive technologies,
thus making it much more difficult, if not impossible, for patent owners and their licensees to
recover the costs of development and research for the market. This would reduce or perhaps
eliminate any incentive for innovation of new software, biotech, or progenitive technologies. The
public and private sectors would certainly be harmed under this scenario. To recoup its costs,
software companies would have to drastically increase the prices at a level unaffordable to many
consumers.
Bowman cannot persuasively argue that he did not plant the second generation of seeds.
Certainly there is no reason that one action cannot simultaneously use a patented good and make
another patented article. Similarly, Bowman is wrong in contending that, because the selfreplication of the first-generation seeds is a consequence of their normal use, that he may use the
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second-generation seeds, based on an analogy to the Supreme Court’s determination in Quanta
that the authorized sale of a product exhausts a patent when the only reasonable and intended use
of the article sold was to practice the patent.185
To begin with, the question in Quanta involved the use of an article acquired through an
authorized sale. In Bowman v. Monsanto, the issue relates to a new copy of the patented article.
Moreover, the court below correctly concluded that there were uses of second-generation soybean seeds other than practicing the patent, namely that those seeds may be used as a commodity
for feed or food. There simply is no argument that planting is the only reasonable and intended
use of the second-generation seed copies resulting from the planting of the first-generation seeds.
When planted, the initial generation of seeds has become spent. Likewise, the secondgeneration seeds qualify as a wholly new article under patent law. Due to the important fact that
the second-generation seeds were not the subjects of an authorized sale, Bowman’s use of those
seeds constitutes infringement.
Taking this argument a step further, any exception to the conventional exhaustion
standards for self-replicating seeds should absolutely not extend to computer software. This is
because Bowman v. Monsanto and the arguments contained within that case hinge on the
particular features of soybean seeds. With soybean seeds, self-replication is a natural occurrence
and a feature particular to soybean seeds. The use of computer software typically results in a
temporary copy of the software on the computer’s random access memory. This is necessary for
the program to run. Although this appears to be self-replication in a literal sense, it is remarkably
different. Soybean seeds replicating is a completely natural phenomenon with a singular
reasonable use. Conversely, computer software replicating is to facilitate the operation of the
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first-generation of software. The principal purpose of self-replication of software is only to make
that particular software run. Its purpose is certainly not self-replication. Moreover, a software
user acquires license to use the software with rights explicitly laid out in the end user license
agreement, the user has not acquired the software through an authorized sale as required for the
exhaustion doctrine to apply.

According to statistics presented by The Software Alliance, the technology industry is
essential to the modern economy; it has, for example, played a critical role in the recovery from
the recent recession.186 Thus, the Bureau of Economic Analysis estimates that the technology,
information, and communications sector (which includes computer hardware and software) grew
by 6.9% in 2011, which accounted for approximately 20% of total national GDP growth that
year.187
Moreover, U.S. technology companies are among the nation’s leading exporters of
products, significantly strengthening the U.S. economy.188 Between January and November 2012,
U.S. companies exported nearly $113 billion of computers and electronic products--about 8% of
total U.S. exports. U.S. Census Bureau, U.S. International Trade in Goods and Services, FT-900
Supplement November 2012, at 1 Ex. 1 (2013).189 Software products contribute approximately
$36 billion in annual exports. See Robert W. Holleyman, BSA President and CEO, Testimony
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before the United States House of Representatives Committee on Energy and Commerce,
Subcommittee on Commerce, Manufacturing and Trade, at 2 (Mar. 16, 2011).190
Investment in the technology industry reflects its critical importance to the American
economy.

191

In 2008, companies invested approximately $46.9 billion in research and

development for software and computer-related services--approximately 16% of total industrial
research and development expenditures for the Nation. Nat’l Sci. Bd., Science and Engineering
Indicators, at 4-21 & 4-23 (2012).192 Companies invested about $45 billion in research for the
computer and electronic products sector in 2008.193 Together, hardware and software account for
roughly 31% of total spending by businesses on research and development.194 Software Alliance
member companies each year spend in excess of $32 billion on research and development to
expand their innovation portfolios.195
Technology firms also are leading innovators. Between 2006 and 2008, 77% of
companies engaged in software development "report[ed] the introduction of a new product or
service compared to the 7% average for all nonmanufacturing industries." Nat’l Sci. Bd., supra,
at 6-47. 196 Computer manufacturers likewise far outstrip the national average for innovation,
with over 50% of companies in the hardware market reporting the innovation of a new product or
service.197
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The above statistics serve to highlight the tremendous importance of the software
industry and the significance of intellectual property protection to software firms. The
intellectual property protections provided by patent law are therefore critical for innovation.
Additionally, with patent law left in an uncertain state, an ambiguous decision would subject
software companies to opportunistic infringement suits. Due to the very high costs of defending
these lawsuits, companies may choose to settle instead of fighting their battles in court,
regardless of the merits of the case. The high lawsuit costs inhibit innovation and divert valuable
resources away from research, development, and production.198
Technology firms argue that the court above properly concluded that exhaustion doctrine
does not actually apply in this case. The longstanding doctrine of patent exhaustion provides that
the initial authorized sale of a patented items terminates all patent rights to that item."199 They
cite to a case on point, namely, United States v. Univis Lens Co., 316 U.S. 241, 251 (1942) ("the
purpose of the patent law is fulfilled with respect to any particular article when the patentee has
received his reward for the use of his invention by the sale of the article") (emphases added).
Additionally, the milestone case of Adams v. Burke provides guidance. In Adams v. Burke200, the
court states that a patent owner who sells a machine or instrument has received all the royalty or
consideration, which he claims for the use of his invention in that particular machine or
instrument. An authorized sale of seeds therefore would exhaust the patent rights in the particular
seeds that were sold.
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Piracy is already a scourge on the computer software industry, resulting in losses of $63.4
billion in 2011.201 Any possible legal loophole or strict interpretation of the patent laws to further
encourage piracy would be devastating. Therefore, it would be folly
for a case concerning soybean seed patents to affect the viability of a completely different
industry relying on patents and copyrights. Furthermore, any restriction on a patent holder’s
rights would naturally lead to the patent holder developing a new way to protect its rights. In the
case of technology, it is foreseeable that a software firm or hardware firm rely more on contract
rights through its licensees. Moreover, when it comes to customers attempting to replicate its
products, software can easily develop a digital distribution model with each user having a unique
access code to limit piracy. Regardless, the consumers have to pay the price of tighter controls
over patent holders’ software. To keep things as they are, Bowman simply needs to lose.

VI.

Conclusion
Bowman v. Monsanto can determine the fate of other products, such as computer

software. Although agriculture and computer technology are very different, the concept that is
being brought to court is a similar one. When people implement computer software, the
computers create temporary copies of the program. Like the plant seeds, computer software
would be characterized as self-replicating. If the case were ruled in favor of the farmers, it would
allow and fuel widespread software piracy. Software users will be able to obtain temporary
copies and replicate them with the intent to either sell or illegally share online because the court
ruling will not extend the patent to these copied versions of the original software. Ultimately,
farmers will not win. The Supreme Court appeared to side in favor of Monsanto during
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questioning. The court appeared skeptical of letting patent rights lapse and the effects it would
have on the creation of new patents. Regardless, even if the court some how does find in favor of
Bowman, farmers and consumers still lose. Monsanto will implement terminator technology.
Technology would shift to prevent it from being replicated, such as digital distribution with
unique keys for software. Hardware would be much closely guarded via contract law. The case
must come out in favor of Monsanto to keep the status quo.
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